- WuXi AppTec (Philadelphia, PA)
- WuXi Advanced Therapies is a leading global cell and gene therapy contract, testing, development, and manufacturing organization (CTDMO) that is dedicated to ... advancing the development and commercialization of cell and gene therapies. Our values include innovation, excellence, and collaboration, which are reflected in our… more
- TalentBurst, Inc (Miami, FL)
- …or Iris Urinalysis instrumentation. * PREFFERED: Microscopy experience. Able to perform cell identification of abnormal cells and particles in blood and/or urine. ... or Iris Urinalysis instrumentation. * PREFFERED: Microscopy experience. Able to perform cell identification of abnormal cells and particles in blood and/or urine.… more
- Detroit Medical Center (Detroit, MI)
- …11. Performs special processing of selective specimens (ie Acid wash, Cell block, Decalcification) according to established guidelines. 12. Maintains daily records, ... such as specimen logs/worksheets, send outs, and special procedure logs. Inputs data for workload. Accurately enters patient demographics data into the laboratory computer system; detects and corrects errors according to laboratory policies and quality… more
- Core Medical-Perm (High Point, NC)
- …Additional Information: **$2,500/year for hospice certification. Mileage reimbursement. Cell phone allowance. Excellent benefits package CoreMedical Group is ... a nationally recognized leader in the medical recruitment and employment industry. We're the only healthcare staffing company to offer our permanent staff a free, all-inclusive tropical vacation. You can earn our Club CoreMed vacation by taking a permanent… more
- Genmab (Yardville, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Whittingham, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Concordia, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Skillman, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Hamilton Square, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Monmouth Junction, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- MUSC (Charleston, SC)
- …post-operative settings, liver cirrhosis, hepatitis, acute kidney injury and sickle cell . Nurses and patient care technicians work collaboratively alongside our ... Hepatologists and medical teams to provide patients and their families with high quality, evidenced based care. MH5W is first unit at MUSC to utilize the new drug Terlipressin in treatment of liver patients with decreased kidney function. The patient… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- MUSC (Charleston, SC)
- …in the care and treatment of Adult Bone Marrow Transplant, CAR-T Cell Therapy, and Malignant Hematology patients. The unit manages patients receiving chemotherapy, ... immunotherapy, transplantation, and those enrolled in clinical trials. The HOPE Unit requires all nurses to complete a National Cancer Institute Collaborative Systemic Therapies Course within the first year of employment in order to become chemotherapy… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
- Genmab (Princeton, NJ)
- …which has resulted in a proprietary pipeline including bispecific T- cell engagers, next-generation immune checkpoint modulators, effector function enhanced ... antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of… more
Related Job Searches:
Cell Assay,
Cell Culture,
Cell Manager,
Cell Phone,
Cell Site,
Cell Tower,
Fuel Cell,
Stem Cell,
Stem Cell Lab,
Stem Cell Scientist